HomeCompareLVZPF vs KMB

LVZPF vs KMB: Dividend Comparison 2026

LVZPF yields 2.87% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $23.1K in total portfolio value
10 years
LVZPF
LVZPF
● Live price
2.87%
Share price
$5.22
Annual div
$0.15
5Y div CAGR
-6.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.7K
Annual income
$164.80
Full LVZPF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — LVZPF vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLVZPFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LVZPF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LVZPF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LVZPF
Annual income on $10K today (after 15% tax)
$244.25/yr
After 10yr DRIP, annual income (after tax)
$140.08/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, KMB beats the other by $4,289.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LVZPF + KMB for your $10,000?

LVZPF: 50%KMB: 50%
100% KMB50/50100% LVZPF
Portfolio after 10yr
$34.3K
Annual income
$2,688.06/yr
Blended yield
7.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

LVZPF
No analyst data
Altman Z
5.1
Piotroski
8/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LVZPF buys
0
KMB buys
0
No recent congressional trades found for LVZPF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLVZPFKMB
Forward yield2.87%5.25%
Annual dividend / share$0.15$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-6.7%17%
Portfolio after 10y$22.7K$45.9K
Annual income after 10y$164.80$5,211.33
Total dividends collected$2.2K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LVZPF vs KMB ($10,000, DRIP)

YearLVZPF PortfolioLVZPF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$10,968$268.10$11,314$613.68$346.00KMB
2$11,992$256.41$12,865$759.19$873.00KMB
3$13,076$244.46$14,709$943.96$1.6KKMB
4$14,224$232.42$16,919$1,180.17$2.7KKMB
5$15,440$220.45$19,588$1,484.33$4.1KKMB
6$16,730$208.66$22,838$1,879.06$6.1KKMB
7$18,098$197.14$26,832$2,395.60$8.7KKMB
8$19,551$185.96$31,788$3,077.63$12.2KKMB
9$21,094$175.16$38,000$3,986.82$16.9KKMB
10$22,736$164.80$45,872$5,211.33$23.1KKMB

LVZPF vs KMB: Complete Analysis 2026

LVZPFStock

Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.

Full LVZPF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this LVZPF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LVZPF vs SCHDLVZPF vs JEPILVZPF vs OLVZPF vs KOLVZPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.